Osteopontin ¿ A potential biomarker of advanced liver disease Radan Bruha; Libor Vitek; Vaclav Smid;

Updated recommendations for the management of metabolic dysfunction¿associated steatotic liver disease (MASLD) by the Latin American working group. Luis Antonio Diaz; Juan Pablo Arab; Francisco Idalsoaga; Javiera Perelli; Javier Vega; Melisa Dirchwolf; Javiera Carreño; Bárbara Samith; Cynthia Valério; Rodrigo Oliveira Moreira; Mónica Acevedo; Javier Brahm; Nelia Hernández; Adrian Gadano; Claudia P. Oliveira; Marco Arrese; Graciela Castro-Narro; Mario G. Pessoa;

Association of sleep patterns and disorders with metabolic dysfunction-associated steatotic liver disease and liver fibrosis in contemporary American adults Guannan Zong; Wangjia Mao; Ming Wen; Xiaoyun Cheng; Guanghui Liu;